{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:09:15Z","timestamp":1785114555331,"version":"3.55.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Gansu Province","award":["24JRRA346"],"award-info":[{"award-number":["24JRRA346"]}]},{"name":"the \u201cCuiying Science and Technology Program\u201d of the Second Hospital of Lanzhou University","award":["CY2023-QN-B03"],"award-info":[{"award-number":["CY2023-QN-B03"]}]},{"name":"China Foundation for International Medical Exchanges","award":["(23)0207"],"award-info":[{"award-number":["(23)0207"]}]},{"DOI":"10.13039\/501100017661","name":"China Health Promotion Foundation","doi-asserted-by":"publisher","award":["(23)1263"],"award-info":[{"award-number":["(23)1263"]}],"id":[{"id":"10.13039\/501100017661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"DOI":"10.1007\/s11481-025-10208-3","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:42:39Z","timestamp":1748259759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RIPK1: A Promising Target for Intervention Neuroinflammation"],"prefix":"10.1007","volume":"20","author":[{"given":"Feixing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjuan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haile","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinliang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"10208_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbadis.2010.06.017","volume":"2011","author":"JI Alvarez","year":"1812","unstructured":"Alvarez JI, Cayrol R, Prat A (1812) Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta 2011:252\u2013264. https:\/\/doi.org\/10.1016\/j.bbadis.2010.06.017","journal-title":"Biochim Biophys Acta"},{"key":"10208_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","volume":"29","author":"U Andersson","year":"2011","unstructured":"Andersson U, Tracey KJ (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29:139\u2013162. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101323","journal-title":"Annu Rev Immunol"},{"key":"10208_CR3","doi-asserted-by":"publisher","first-page":"116123","DOI":"10.1016\/j.ejmech.2024.116123","volume":"265","author":"Y Bai","year":"2024","unstructured":"Bai Y, Qiao Y, Li M, Yang W, Chen H, Wu Y, Zhang H (2024) RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development. Eur J Med Chem 265:116123. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116123","journal-title":"Eur J Med Chem"},{"key":"10208_CR4","doi-asserted-by":"publisher","first-page":"165260","DOI":"10.1016\/j.bbadis.2018.09.012","volume":"1866","author":"D Barthels","year":"2018","unstructured":"Barthels D, Das H (2018) Current Advances in Ischemic Stroke Research and Therapies, Biochimica et Biophysica Acta. Mol Basis Dis 1866:165260. https:\/\/doi.org\/10.1016\/j.bbadis.2018.09.012","journal-title":"Mol Basis Dis"},{"key":"10208_CR5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS (2021) Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol 18:1106\u20131121. https:\/\/doi.org\/10.1038\/s41423-020-00630-3","journal-title":"Cell Mol Immunol"},{"key":"10208_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molcel.2008.05.014","volume":"30","author":"MJM Bertrand","year":"2008","unstructured":"Bertrand MJM, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA (2008) cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30:689\u2013700. https:\/\/doi.org\/10.1016\/j.molcel.2008.05.014","journal-title":"Mol Cell"},{"key":"10208_CR7","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, Readhead B, Dudley JT, Spangenberg EE, Green KN, Belfiore R, Winslow W, Oddo S (2017) Necroptosis activation in Alzheimer\u2019s disease. Nat Neurosci 20:1236\u20131246. https:\/\/doi.org\/10.1038\/nn.4608","journal-title":"Nat Neurosci"},{"key":"10208_CR8","doi-asserted-by":"publisher","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Liu J, Wang B, Sun M, Yang H (2022) Microglia in the Neuroinflammatory Pathogenesis of Alzheimer\u2019s Disease and Related Therapeutic Targets. Front Immunol 13:856376. https:\/\/doi.org\/10.3389\/fimmu.2022.856376","journal-title":"Front Immunol"},{"key":"10208_CR9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/STROKEAHA.122.036946","volume":"53","author":"E Candelario-Jalil","year":"2022","unstructured":"Candelario-Jalil E, Dijkhuizen RM, Magnus T (2022) Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities. Stroke 53:1473\u20131486. https:\/\/doi.org\/10.1161\/STROKEAHA.122.036946","journal-title":"Stroke"},{"key":"10208_CR10","doi-asserted-by":"publisher","first-page":"105297","DOI":"10.1016\/j.phrs.2020.105297","volume":"163","author":"L Cao","year":"2021","unstructured":"Cao L, Mu W (2021) Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications. Pharmacol Res 163:105297. https:\/\/doi.org\/10.1016\/j.phrs.2020.105297","journal-title":"Pharmacol Res"},{"key":"10208_CR11","doi-asserted-by":"publisher","unstructured":"Chavez-Tapia N, Sayeed MA, Luxmi S, Kasper DJ, Xue F, Shen Y, Fan W, Yuan W, Du B (2024) Safety and efficacy of selective RIPK1 inhibitor SIR1\u2013365 in hospitalized patients with severe COVID-19: A multicenter, randomized, double-blind, phase 1b trial, J Intensive Med S2667100X24000938. https:\/\/doi.org\/10.1016\/j.jointm.2024.07.003","DOI":"10.1016\/j.jointm.2024.07.003"},{"key":"10208_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41419-019-1716-9","volume":"10","author":"A-Q Chen","year":"2019","unstructured":"Chen A-Q, Fang Z, Chen X-L, Yang S, Zhou Y-F, Mao L, Xia Y-P, Jin H-J, Li Y-N, You M-F, Wang X-X, Lei H, He Q-W, Hu B (2019) Microglia-derived TNF-\u03b1 mediates endothelial necroptosis aggravating blood brain\u2013barrier disruption after ischemic stroke. Cell Death Dis 10:487. https:\/\/doi.org\/10.1038\/s41419-019-1716-9","journal-title":"Cell Death Dis"},{"key":"10208_CR13","doi-asserted-by":"publisher","first-page":"e52254","DOI":"10.15252\/embr.202052254","volume":"22","author":"I-T Chen","year":"2021","unstructured":"Chen I-T, Chen H-C, Lo Y-H, Lai P-Y, Hsieh F-Y, Wu Y-H, Shih H-M, Lai M-Z (2021) Promyelocytic leukemia protein targets MK2 to promote cytotoxicity. EMBO Rep 22:e52254. https:\/\/doi.org\/10.15252\/embr.202052254","journal-title":"EMBO Rep"},{"key":"10208_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/molecules28010052","volume":"28","author":"X-Y Chen","year":"2022","unstructured":"Chen X-Y, Dai Y-H, Wan X-X, Hu X-M, Zhao W-J, Ban X-X, Wan H, Huang K, Zhang Q, Xiong K (2022) ZBP1-Mediated Necroptosis: Mechanisms and Therapeutic Implications. Molecules 28:52. https:\/\/doi.org\/10.3390\/molecules28010052","journal-title":"Molecules"},{"key":"10208_CR15","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/cancers11111623","volume":"11","author":"Z Choo","year":"2019","unstructured":"Choo Z, Loh AHP, Chen ZX (2019) Destined to Die: Apoptosis and Pediatric Cancers. Cancers (Basel) 11:1623. https:\/\/doi.org\/10.3390\/cancers11111623","journal-title":"Cancers (Basel)"},{"key":"10208_CR16","doi-asserted-by":"publisher","unstructured":"Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu Y-F, Wang Q, Krueger BJ, Ren Z, Keebler J, Han Y, Levy SE, Boone BE, Wimbish JR, Waite LL, Jones AL, Carulli JP, Day-Williams AG, Staropoli JF, Xin WW, Chesi A, Raphael AR, McKenna-Yasek D, Cady J, de Jong JV, Kenna KP, Smith BN, Topp S, Miller J, Gkazi A, Consortium FS, Al-Chalabi A, van den Berg LH, Veldink J, Silani V, Ticozzi N, Shaw CE, Baloh RH, Appel S, Simpson E, Lagier-Tourenne C, Pulst SM, Gibson S, Trojanowski JQ, Elman L, McCluskey L, Grossman M, Shneider NA, Chung WK, Ravits JM, Glass JD, Sims KB, Deerlin VMV, Maniatis T, Hayes SD, Ordureau A, Swarup S, Landers J, Baas F, Allen AS, Bedlack RS, Harper JW, Gitler AD, Rouleau GA, Brown R, Harms MB, Cooper GM, Harris T, Myers RM, Goldstein DB (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways, Science (New York, N.Y.) 347: 1436. https:\/\/doi.org\/10.1126\/science.aaa3650","DOI":"10.1126\/science.aaa3650"},{"key":"10208_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12931-024-02670-z","volume":"25","author":"P-F Clot","year":"2024","unstructured":"Clot P-F, Farenc C, Suratt BT, Krahnke T, Tardat A, Florian P, Pomponio R, Patel N, Wiekowski M, Lin Y, Terrier B, Staudinger H (2024) Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study. Respir Res 25:107. https:\/\/doi.org\/10.1186\/s12931-024-02670-z","journal-title":"Respir Res"},{"key":"10208_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol 35:441. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052358","journal-title":"Annu Rev Immunol"},{"key":"10208_CR19","unstructured":"D.T. Inc, Denali Therapeutics Announces Positive Clinical Results and Regulatory Progress for Development Programs in Amyotrophic Lateral Sclerosis (ALS), GlobeNewswire News Room (2021). https:\/\/www.globenewswire.com\/en\/news-release\/2021\/10\/06\/2309876\/0\/en\/Denali-Therapeutics-Announces-Positive-Clinical-Results-and-Regulatory-Progress-for-Development-Programs-in-Amyotrophic-Lateral-Sclerosis-ALS.html. Accessed 26 March 2025."},{"key":"10208_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909. https:\/\/doi.org\/10.1016\/s0896-6273(03)00568-3","journal-title":"Neuron"},{"key":"10208_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112\u2013119. https:\/\/doi.org\/10.1038\/nchembio711","journal-title":"Nat Chem Biol"},{"key":"10208_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313\u2013321. https:\/\/doi.org\/10.1038\/nchembio.83","journal-title":"Nat Chem Biol"},{"key":"10208_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/cdd.2012.133","volume":"20","author":"A Degterev","year":"2013","unstructured":"Degterev A, Maki JL, Yuan J (2013) Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ 20:366. https:\/\/doi.org\/10.1038\/cdd.2012.133","journal-title":"Cell Death Differ"},{"key":"10208_CR24","doi-asserted-by":"publisher","first-page":"9714","DOI":"10.1073\/pnas.1901179116","volume":"116","author":"A Degterev","year":"2019","unstructured":"Degterev A, Ofengeim D, Yuan J (2019) Targeting RIPK1 for the treatment of human diseases. Proc Natl Acad Sci U S A 116:9714\u20139722. https:\/\/doi.org\/10.1073\/pnas.1901179116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10208_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.14336\/AD.2018.0728","volume":"10","author":"X-X Deng","year":"2019","unstructured":"Deng X-X, Li S-S, Sun F-Y (2019) Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke via Inhibition of RIPK1-Mediated RIPK3\/MLKL Signaling. Aging Dis 10:807. https:\/\/doi.org\/10.14336\/AD.2018.0728","journal-title":"Aging Dis"},{"key":"10208_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cyto.2015.06.004","volume":"76","author":"S Dhib-Jalbut","year":"2015","unstructured":"Dhib-Jalbut S, Kalvakolanu DV (2015) Microglia and necroptosis: The culprits of neuronal cell death in multiple sclerosis. Cytokine 76:583\u2013584. https:\/\/doi.org\/10.1016\/j.cyto.2015.06.004","journal-title":"Cytokine"},{"key":"10208_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/bs.ircmb.2019.12.006","volume":"353","author":"PA Dion\u00edsio","year":"2020","unstructured":"Dion\u00edsio PA, Amaral JD, Rodrigues CMP (2020) Molecular mechanisms of necroptosis and relevance for neurodegenerative diseases. Int Rev Cell Mol Biol 353:31\u201382. https:\/\/doi.org\/10.1016\/bs.ircmb.2019.12.006","journal-title":"Int Rev Cell Mol Biol"},{"key":"10208_CR28","doi-asserted-by":"publisher","unstructured":"Dj S (2000) Toward a comprehensive theory for Alzheimer\u2019s disease. Hypothesis: Alzheimer\u2019s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein, Annals of the New York Academy of Sciences 924. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05554.x.","DOI":"10.1111\/j.1749-6632.2000.tb05554.x"},{"key":"10208_CR29","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.celrep.2015.11.009","volume":"13","author":"P Draber","year":"2015","unstructured":"Draber P, Kupka S, Reichert M, Draberova H, Lafont E, de Miguel D, Spilgies L, Surinova S, Taraborrelli L, Hartwig T, Rieser E, Martino L, Rittinger K, Walczak H (2015) LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes. Cell Rep 13:2258\u20132272. https:\/\/doi.org\/10.1016\/j.celrep.2015.11.009","journal-title":"Cell Rep"},{"key":"10208_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.immuni.2014.12.031","volume":"42","author":"BH Duong","year":"2015","unstructured":"Duong BH, Onizawa M, Oses-Prieto JA, Advincula R, Burlingame A, Malynn BA, Ma A (2015) A20 restricts ubiquitination of pro-interleukin-1\u03b2 protein complexes and suppresses NLRP3 inflammasome activity. Immunity 42:55\u201367. https:\/\/doi.org\/10.1016\/j.immuni.2014.12.031","journal-title":"Immunity"},{"key":"10208_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2014.03.018","volume":"54","author":"PR Elliott","year":"2014","unstructured":"Elliott PR, Nielsen SV, Marco-Casanova P, Fiil BK, Keusekotten K, Mailand N, Freund SMV, Gyrd-Hansen M, Komander D (2014) Molecular basis and regulation of OTULIN-LUBAC interaction. Mol Cell 54:335\u2013348. https:\/\/doi.org\/10.1016\/j.molcel.2014.03.018","journal-title":"Mol Cell"},{"key":"10208_CR32","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s10495-014-1041-9","volume":"19","author":"LE Estlack","year":"2014","unstructured":"Estlack LE, Roth CC, Thompson GL, Lambert WA, Ibey BL (2014) Nanosecond pulsed electric fields modulate the expression of Fas\/CD95 death receptor pathway regulators in U937 and Jurkat Cells. Apoptosis 19:1755\u20131768. https:\/\/doi.org\/10.1007\/s10495-014-1041-9","journal-title":"Apoptosis"},{"key":"10208_CR33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.molcel.2013.06.004","volume":"50","author":"BK Fiil","year":"2013","unstructured":"Fiil BK, Damgaard RB, Wagner SA, Keusekotten K, Fritsch M, Bekker-Jensen S, Mailand N, Choudhary C, Komander D, Gyrd-Hansen M (2013) OTULIN restricts Met1-linked ubiquitination to control innate immune signaling. Mol Cell 50:818\u2013830. https:\/\/doi.org\/10.1016\/j.molcel.2013.06.004","journal-title":"Mol Cell"},{"key":"10208_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nn.4000","volume":"18","author":"A Freischmidt","year":"2015","unstructured":"Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M\u00fcller K, Marroquin N, Nordin F, H\u00fcbers A, Weydt P, Pinto S, Press R, Millecamps S, Molko N, Bernard E, Desnuelle C, Soriani M-H, Dorst J, Graf E, Nordstr\u00f6m U, Feiler MS, Putz S, Boeckers TM, Meyer T, Winkler AS, Winkelman J, de Carvalho M, Thal DR, Otto M, Br\u00e4nnstr\u00f6m T, Volk AE, Kursula P, Danzer KM, Lichtner P, Dikic I, Meitinger T, Ludolph AC, Strom TM, Andersen PM, Weishaupt JH (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18:631\u2013636. https:\/\/doi.org\/10.1038\/nn.4000","journal-title":"Nat Neurosci"},{"key":"10208_CR35","doi-asserted-by":"publisher","first-page":"170228","DOI":"10.1098\/rsob.170228","volume":"7","author":"GR Frost","year":"2017","unstructured":"Frost GR, Li Y-M (2017) The role of astrocytes in amyloid production and Alzheimer\u2019s disease. Open Biol 7:170228. https:\/\/doi.org\/10.1098\/rsob.170228","journal-title":"Open Biol"},{"key":"10208_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature09816","volume":"471","author":"B Gerlach","year":"2011","unstructured":"Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, Webb AI, Rickard JA, Anderton H, Wong WW-L, Nachbur U, Gangoda L, Warnken U, Purcell AW, Silke J, Walczak H (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471:591\u2013596. https:\/\/doi.org\/10.1038\/nature09816","journal-title":"Nature"},{"key":"10208_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13195-015-0126-1","volume":"7","author":"D Gomez-Nicola","year":"2015","unstructured":"Gomez-Nicola D, Boche D (2015) Post-mortem analysis of neuroinflammatory changes in human Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 7:42. https:\/\/doi.org\/10.1186\/s13195-015-0126-1","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10208_CR38","doi-asserted-by":"publisher","first-page":"585880","DOI":"10.3389\/fimmu.2020.585880","volume":"11","author":"P Gough","year":"2020","unstructured":"Gough P, Myles IA (2020) Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects. Front Immunol 11:585880. https:\/\/doi.org\/10.3389\/fimmu.2020.585880","journal-title":"Front Immunol"},{"key":"10208_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/cpt.1615","volume":"107","author":"HW Grievink","year":"2020","unstructured":"Grievink HW, Heuberger JAAC, Huang F, Chaudhary R, Birkhoff WAJ, Tonn GR, Mosesova S, Erickson R, Moerland M, Haddick PCG, Scearce-Levie K, Ho C, Groeneveld GJ (2020) DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers. Clin Pharmacol Ther 107:406\u2013414. https:\/\/doi.org\/10.1002\/cpt.1615","journal-title":"Clin Pharmacol Ther"},{"key":"10208_CR40","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","volume":"10","author":"K Haruwaka","year":"2019","unstructured":"Haruwaka K, Ikegami A, Tachibana Y, Ohno N, Konishi H, Hashimoto A, Matsumoto M, Kato D, Ono R, Kiyama H, Moorhouse AJ, Nabekura J, Wake H (2019) Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun 10:5816. https:\/\/doi.org\/10.1038\/s41467-019-13812-z","journal-title":"Nat Commun"},{"key":"10208_CR41","doi-asserted-by":"publisher","first-page":"e13690","DOI":"10.1111\/cts.13690","volume":"17","author":"A Hincelin-Mery","year":"2024","unstructured":"Hincelin-Mery A, Nicolas X, Cantalloube C, Pomponio R, Lewanczyk P, Benamor M, Ofengeim D, Krupka E, Hsiao-Nakamoto J, Eastenson A, Atassi N (2024) Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants. Clin Transl Sci 17:e13690. https:\/\/doi.org\/10.1111\/cts.13690","journal-title":"Clin Transl Sci"},{"key":"10208_CR42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(95)90070-5","volume":"81","author":"H Hsu","year":"1995","unstructured":"Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81:495\u2013504. https:\/\/doi.org\/10.1016\/0092-8674(95)90070-5","journal-title":"Cell"},{"key":"10208_CR43","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41419-019-1809-5","volume":"10","author":"Y-B Hu","year":"2019","unstructured":"Hu Y-B, Zhang Y-F, Wang H, Ren R-J, Cui H-L, Huang W-Y, Cheng Q, Chen H-Z, Wang G (2019) miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson\u2019s disease. Cell Death Dis 10:589. https:\/\/doi.org\/10.1038\/s41419-019-1809-5","journal-title":"Cell Death Dis"},{"key":"10208_CR44","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.14336\/AD.2023.0807","volume":"15","author":"Q Huang","year":"2024","unstructured":"Huang Q, Wang Y, Chen S, Liang F (2024) Glycometabolic Reprogramming of Microglia in Neurodegenerative Diseases: Insights from Neuroinflammation. Aging Dis 15:1155\u20131175. https:\/\/doi.org\/10.14336\/AD.2023.0807","journal-title":"Aging Dis"},{"key":"10208_CR45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13195-017-0308-0","volume":"9","author":"J Hugon","year":"2017","unstructured":"Hugon J, Mouton-Liger F, Dumurgier J, Paquet C (2017) PKR involvement in Alzheimer\u2019s disease. Alzheimers Res Ther 9:83. https:\/\/doi.org\/10.1186\/s13195-017-0308-0","journal-title":"Alzheimers Res Ther"},{"key":"10208_CR46","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.celrep.2018.01.089","volume":"22","author":"A Iannielli","year":"2018","unstructured":"Iannielli A, Bido S, Folladori L, Segnali A, Cancellieri C, Maresca A, Massimino L, Rubio A, Morabito G, Caporali L, Tagliavini F, Musumeci O, Gregato G, Bezard E, Carelli V, Tiranti V, Broccoli V (2018) Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson\u2019s Disease Models. Cell Rep 22:2066\u20132079. https:\/\/doi.org\/10.1016\/j.celrep.2018.01.089","journal-title":"Cell Rep"},{"key":"10208_CR47","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T (2023) Microglia Mediated Neuroinflammation in Parkinson\u2019s Disease. Cells 12:1012. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"key":"10208_CR48","doi-asserted-by":"publisher","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","volume":"2","author":"A Isra\u00ebl","year":"2010","unstructured":"Isra\u00ebl A (2010) The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2:a000158. https:\/\/doi.org\/10.1101\/cshperspect.a000158","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10208_CR49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1126\/science.aaf6803","volume":"353","author":"Y Ito","year":"2016","unstructured":"Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, Hitomi J, Zhu H, Chen H, Mayo L, Geng J, Amin P, DeWitt JP, Mookhtiar AK, Florez M, Ouchida AT, Fan J, Pasparakis M, Kelliher MA, Ravits J, Yuan J (2016) RIPK1 Mediates Axonal Degeneration By Promoting Inflammation and Necroptosis in ALS. Science (New York, N.Y) 353:603. https:\/\/doi.org\/10.1126\/science.aaf6803","journal-title":"Science (New York, N.Y)"},{"key":"10208_CR50","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.molcel.2017.05.003","volume":"66","author":"I Jaco","year":"2017","unstructured":"Jaco I, Annibaldi A, Lalaoui N, Wilson R, Tenev T, Laurien L, Kim C, Jamal K, Wicky John S, Liccardi G, Chau D, Murphy JM, Brumatti G, Feltham R, Pasparakis M, Silke J, Meier P (2017) MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death. Mol Cell 66:698-710.e5. https:\/\/doi.org\/10.1016\/j.molcel.2017.05.003","journal-title":"Mol Cell"},{"key":"10208_CR51","doi-asserted-by":"publisher","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","volume":"288","author":"WJ Kaiser","year":"2013","unstructured":"Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, Sehon CA, Marquis RW, Bertin J, Mocarski ES (2013) Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL. J Biol Chem 288:31268. https:\/\/doi.org\/10.1074\/jbc.M113.462341","journal-title":"J Biol Chem"},{"key":"10208_CR52","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","volume":"15","author":"A Kanayama","year":"2004","unstructured":"Kanayama A, Seth RB, Sun L, Ea C-K, Hong M, Shaito A, Chiu Y-H, Deng L, Chen ZJ (2004) TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell 15:535\u2013548. https:\/\/doi.org\/10.1016\/j.molcel.2004.08.008","journal-title":"Mol Cell"},{"key":"10208_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s1074-7613(00)80535-x","volume":"8","author":"MA Kelliher","year":"1998","unstructured":"Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P (1998) The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8:297\u2013303. https:\/\/doi.org\/10.1016\/s1074-7613(00)80535-x","journal-title":"Immunity"},{"key":"10208_CR54","doi-asserted-by":"publisher","unstructured":"Knezevic D, Mizrahi R (2018) Molecular imaging of neuroinflammation in Alzheimer\u2019s disease and mild cognitive impairment, Progress Neuro-Psychopharmacol Biol Psychiatry 80. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.05.007","DOI":"10.1016\/j.pnpbp.2017.05.007"},{"key":"10208_CR55","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00401-019-02103-y","volume":"139","author":"MJ Koper","year":"2020","unstructured":"Koper MJ, Van Schoor E, Ospitalieri S, Vandenberghe R, Vandenbulcke M, von Arnim CAF, Tousseyn T, Balusu S, De Strooper B, Thal DR (2020) Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer\u2019s disease. Acta Neuropathol 139:463\u2013484. https:\/\/doi.org\/10.1007\/s00401-019-02103-y","journal-title":"Acta Neuropathol"},{"key":"10208_CR56","doi-asserted-by":"publisher","first-page":"aag2045","DOI":"10.1126\/sciimmunol.aag2045","volume":"1","author":"T Kuriakose","year":"2016","unstructured":"Kuriakose T, Man SM, Malireddi RKS, Karki R, Kesavardhana S, Place DE, Neale G, Vogel P, Kanneganti T-D (2016) ZBP1\/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol 1:aag2045. https:\/\/doi.org\/10.1126\/sciimmunol.aag2045","journal-title":"Sci Immunol"},{"key":"10208_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh S-H (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Translational Neurodegeneration 9:42. https:\/\/doi.org\/10.1186\/s40035-020-00221-2","journal-title":"Translational Neurodegeneration"},{"key":"10208_CR58","doi-asserted-by":"publisher","first-page":"104469","DOI":"10.1016\/j.neuint.2019.104469","volume":"129","author":"S Lautrup","year":"2019","unstructured":"Lautrup S, Lou G, Aman Y, Nilsen H, Tao J, Fang EF (2019) Microglial mitophagy mitigates neuroinflammation in Alzheimer\u2019s disease. Neurochem Int 129:104469. https:\/\/doi.org\/10.1016\/j.neuint.2019.104469","journal-title":"Neurochem Int"},{"key":"10208_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17:157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","journal-title":"Nat Rev Neurol"},{"key":"10208_CR60","doi-asserted-by":"publisher","first-page":"1159743","DOI":"10.3389\/fimmu.2023.1159743","volume":"14","author":"W Li","year":"2023","unstructured":"Li W, Yuan J (2023) Targeting RIPK1 kinase for modulating inflammation in human diseases. Front Immunol 14:1159743. https:\/\/doi.org\/10.3389\/fimmu.2023.1159743","journal-title":"Front Immunol"},{"key":"10208_CR61","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cell.2012.06.019","volume":"150","author":"J Li","year":"2012","unstructured":"Li J, McQuade T, Siemer AB, Napetschnig J, Moriwaki K, Hsiao Y-S, Damko E, Moquin D, Walz T, McDermott A, Chan FK-M, Wu H (2012) The RIP1\/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150:339\u2013350. https:\/\/doi.org\/10.1016\/j.cell.2012.06.019","journal-title":"Cell"},{"key":"10208_CR62","doi-asserted-by":"publisher","first-page":"107979","DOI":"10.1016\/j.pharmthera.2021.107979","volume":"231","author":"S Li","year":"2022","unstructured":"Li S, Qu L, Wang X, Kong L (2022) Novel insights into RIPK1 as a promising target for future Alzheimer\u2019s disease treatment. Pharmacol Ther 231:107979. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107979","journal-title":"Pharmacol Ther"},{"key":"10208_CR63","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/cts.13580","volume":"16","author":"J Lickliter","year":"2023","unstructured":"Lickliter J, Wang S, Zhang W, Zhu H, Wang J, Zhao C, Shen H, Wang Y (2023) A phase I randomized, double-blinded, placebo-controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjects. Clin Transl Sci 16:1691\u20131703. https:\/\/doi.org\/10.1111\/cts.13580","journal-title":"Clin Transl Sci"},{"key":"10208_CR64","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature20558","volume":"540","author":"J Lin","year":"2016","unstructured":"Lin J, Kumari S, Kim C, Van T-M, Wachsmuth L, Polykratis A, Pasparakis M (2016) RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature 540:124\u2013128. https:\/\/doi.org\/10.1038\/nature20558","journal-title":"Nature"},{"key":"10208_CR65","doi-asserted-by":"publisher","unstructured":"Liu S, Liu H, Johnston A, Hanna-Addams S, Reynoso E, Xiang Y, Wang Z (2017) MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis, Proc Natl Acad Sci USA 114. https:\/\/doi.org\/10.1073\/pnas.1707531114","DOI":"10.1073\/pnas.1707531114"},{"key":"10208_CR66","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell 179:312. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","journal-title":"Cell"},{"key":"10208_CR67","doi-asserted-by":"publisher","first-page":"9920962","DOI":"10.1155\/2021\/9920962","volume":"2021","author":"D Ma","year":"2021","unstructured":"Ma D, Li Y, Zhu Y, Wei W, Zhang L, Li Y, Li L, Zhang L (2021) Cornel Iridoid Glycoside Ameliorated Alzheimer\u2019s Disease-Like Pathologies and Necroptosis through RIPK1\/MLKL Pathway in Young and Aged SAMP8 Mice. Evid-Based Complemen Alternative Med Ecam 2021:9920962. https:\/\/doi.org\/10.1155\/2021\/9920962","journal-title":"Evid-Based Complemen Alternative Med Ecam"},{"key":"10208_CR68","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ana.24242","volume":"76","author":"P Maggi","year":"2014","unstructured":"Maggi P, Cummings Macri SM, Gait\u00e1n MI, Leibovitch E, Wholer JE, Knight HL, Ellis M, Wu T, Silva AC, Massacesi L, Jacobson S, Westmoreland S, Reich DS (2014) The formation of inflammatory demyelinated lesions in cerebral white matter. Ann Neurol 76:594\u2013608. https:\/\/doi.org\/10.1002\/ana.24242","journal-title":"Ann Neurol"},{"key":"10208_CR69","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fcimb.2019.00406","volume":"9","author":"RKS Malireddi","year":"2019","unstructured":"Malireddi RKS, Kesavardhana S, Kanneganti T-D (2019) ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome\/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis). Front Cell Infect Microbiol 9:406. https:\/\/doi.org\/10.3389\/fcimb.2019.00406","journal-title":"Front Cell Infect Microbiol"},{"key":"10208_CR70","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature08971","volume":"465","author":"H Maruyama","year":"2010","unstructured":"Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M, Nodera H, Suzuki H, Komure O, Matsuura S, Kobatake K, Morimoto N, Abe K, Suzuki N, Aoki M, Kawata A, Hirai T, Kato T, Ogasawara K, Hirano A, Takumi T, Kusaka H, Hagiwara K, Kaji R, Kawakami H (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465:223\u2013226. https:\/\/doi.org\/10.1038\/nature08971","journal-title":"Nature"},{"key":"10208_CR71","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00401-018-1933-9","volume":"137","author":"ME McCauley","year":"2018","unstructured":"McCauley ME, Baloh RH (2018) Inflammation in ALS\/FTD pathogenesis. Acta Neuropathol 137:715. https:\/\/doi.org\/10.1007\/s00401-018-1933-9","journal-title":"Acta Neuropathol"},{"key":"10208_CR72","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3389\/fphar.2020.01123","volume":"11","author":"A Mela","year":"2020","unstructured":"Mela A, Poniatowski \u0141A, Drop B, Furtak-Niczyporuk M, Jaroszy\u0144ski J, Wrona W, Staniszewska A, D\u0105browski J, Czajka A, Jagielska B, Wojciechowska M, Niewada M (2020) Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015\u20132018 Years. Front Pharmacol 11:1123. https:\/\/doi.org\/10.3389\/fphar.2020.01123","journal-title":"Front Pharmacol"},{"key":"10208_CR73","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14737167.2023.2140139","volume":"23","author":"A Mela","year":"2023","unstructured":"Mela A, Rdzanek E, Tysarowski A, Sakowicz M, Jaroszy\u0144ski J, Furtak-Niczyporuk M, \u017burek G, Poniatowski \u0141A, Jagielska B (2023) The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology. Expert Rev Pharmacoecon Outcomes Res 23:43\u201354. https:\/\/doi.org\/10.1080\/14737167.2023.2140139","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10208_CR74","doi-asserted-by":"publisher","first-page":"E2001","DOI":"10.1073\/pnas.1722013115","volume":"115","author":"H Meng","year":"2018","unstructured":"Meng H, Liu Z, Li X, Wang H, Jin T, Wu G, Shan B, Christofferson DE, Qi C, Yu Q, Li Y, Yuan J (2018) Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis. Proc Natl Acad Sci U S A 115:E2001\u2013E2009. https:\/\/doi.org\/10.1073\/pnas.1722013115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10208_CR75","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41573-020-0071-y","volume":"19","author":"L Mifflin","year":"2020","unstructured":"Mifflin L, Ofengeim D, Yuan J (2020) Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nat Rev Drug Discov 19:553\u2013571. https:\/\/doi.org\/10.1038\/s41573-020-0071-y","journal-title":"Nat Rev Drug Discov"},{"key":"10208_CR76","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/j.1582-4934.2009.00849.x","volume":"13","author":"M Morel","year":"2009","unstructured":"Morel M, Couturier J, Lafay-Chebassier C, Paccalin M, Page G (2009) PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer\u2019s disease. J Cell Mol Med 13:1476\u20131488. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00849.x","journal-title":"J Cell Mol Med"},{"key":"10208_CR77","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1182\/bloodadvances.2021004438","volume":"5","author":"P M\u00fcller","year":"2021","unstructured":"M\u00fcller P, Baldauf CK, Haage TR, Waldleben AM, Richter F, Pfizenmaier K, Fischer T (2021) Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F\u2013induced disease. Blood Adv 5:5349. https:\/\/doi.org\/10.1182\/bloodadvances.2021004438","journal-title":"Blood Adv"},{"key":"10208_CR78","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1159\/000524152","volume":"15","author":"T Nakagawa","year":"2022","unstructured":"Nakagawa T, Hayashi K, Ogawa A, Oda G, Onishi I, Yamamoto M, Mori M, Fujioka T, Ishikawa T, Okamoto K, Uetake H (2022) Bone Marrow Carcinomatosis in a Stage IV Breast Cancer Patient Treated by Letrozole as First-Line Endocrine Therapy, Case Rep. Oncol 15:436\u2013441. https:\/\/doi.org\/10.1159\/000524152","journal-title":"Oncol"},{"key":"10208_CR79","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41416-022-02020-0","volume":"128","author":"C N\u00f6ssing","year":"2022","unstructured":"N\u00f6ssing C, Ryan KM (2022) 50 years on and still very much alive: \u2018Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.\u2019 Br J Cancer 128:426. https:\/\/doi.org\/10.1038\/s41416-022-02020-0","journal-title":"Br J Cancer"},{"key":"10208_CR80","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.celrep.2015.02.051","volume":"10","author":"D Ofengeim","year":"2015","unstructured":"Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP, Ye J, Zhang X, Chang A, Vakifahmetoglu-Norberg H, Geng J, Py B, Zhou W, Amin P, Berlink Lima J, Qi C, Yu Q, Trapp B, Yuan J (2015) Activation of necroptosis in multiple sclerosis. Cell Rep 10:1836\u20131849. https:\/\/doi.org\/10.1016\/j.celrep.2015.02.051","journal-title":"Cell Rep"},{"key":"10208_CR81","doi-asserted-by":"publisher","first-page":"E8788","DOI":"10.1073\/pnas.1714175114","volume":"114","author":"D Ofengeim","year":"2017","unstructured":"Ofengeim D, Mazzitelli S, Ito Y, DeWitt JP, Mifflin L, Zou C, Das S, Adiconis X, Chen H, Zhu H, Kelliher MA, Levin JZ, Yuan J (2017) RIPK1 mediates a disease-associated microglial response in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 114:E8788. https:\/\/doi.org\/10.1073\/pnas.1714175114","journal-title":"Proc Natl Acad Sci USA"},{"key":"10208_CR82","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41418-019-0408-4","volume":"27","author":"M O\u00f1ate","year":"2020","unstructured":"O\u00f1ate M, Catenaccio A, Salvadores N, Saquel C, Martinez A, Moreno-Gonzalez I, Gamez N, Soto P, Soto C, Hetz C, Court FA (2020) The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease. Cell Death Differ 27:1169\u20131185. https:\/\/doi.org\/10.1038\/s41418-019-0408-4","journal-title":"Cell Death Differ"},{"key":"10208_CR83","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1126\/science.aau2818","volume":"362","author":"P Orning","year":"2018","unstructured":"Orning P, Weng D, Starheim K, Ratner D, Best Z, Lee B, Brooks A, Xia S, Wu H, Kelliher MA, Berger SB, Gough PJ, Bertin J, Proulx MM, Goguen JD, Kayagaki N, Fitzgerald KA, Lien E (2018) Pathogen blockade of TAK1 triggers caspase-8 dependent cleavage of Gasdermin D and cell death. Science 362:1064\u20131069. https:\/\/doi.org\/10.1126\/science.aau2818","journal-title":"Science"},{"key":"10208_CR84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnagi.2018.00114","volume":"10","author":"BG Perez-Nievas","year":"2018","unstructured":"Perez-Nievas BG, Serrano-Pozo A (2018) Deciphering the Astrocyte Reaction in Alzheimer\u2019s Disease. Front Aging Neurosci 10:114. https:\/\/doi.org\/10.3389\/fnagi.2018.00114","journal-title":"Front Aging Neurosci"},{"key":"10208_CR85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tibs.2018.11.002","volume":"44","author":"EJ Petrie","year":"2019","unstructured":"Petrie EJ, Czabotar PE, Murphy JM (2019) The Structural Basis of Necroptotic Cell Death Signaling. Trends Biochem Sci 44:53\u201363. https:\/\/doi.org\/10.1016\/j.tibs.2018.11.002","journal-title":"Trends Biochem Sci"},{"key":"10208_CR86","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1073\/pnas.1403252111","volume":"111","author":"NH Philip","year":"2014","unstructured":"Philip NH, Dillon CP, Snyder AG, Fitzgerald P, Wynosky-Dolfi MA, Zwack EE, Hu B, Fitzgerald L, Mauldin EA, Copenhaver AM, Shin S, Wei L, Parker M, Zhang J, Oberst A, Green DR, Brodsky IE (2014) Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-\u03baB and MAPK signaling. Proc Natl Acad Sci U S A 111:7385\u20137390. https:\/\/doi.org\/10.1073\/pnas.1403252111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10208_CR87","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag A-E, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"10208_CR88","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.4049\/jimmunol.1400590","volume":"193","author":"A Polykratis","year":"2014","unstructured":"Polykratis A, Hermance N, Zelic M, Roderick J, Kim C, Van T-M, Lee TH, Chan FKM, Pasparakis M, Kelliher MA (2014) Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J Immunol 193:1539\u20131543. https:\/\/doi.org\/10.4049\/jimmunol.1400590","journal-title":"J Immunol"},{"key":"10208_CR89","doi-asserted-by":"publisher","first-page":"106612","DOI":"10.1016\/j.eplepsyres.2021.106612","volume":"173","author":"\u0141A Poniatowski","year":"2021","unstructured":"Poniatowski \u0141A, Cudna A, Kurczych K, Bronisz E, Kurkowska-Jastrz\u0119bska I (2021) Kinetics of serum brain-derived neurotrophic factor (BDNF) concentration levels in epileptic patients after generalized tonic-clonic seizures. Epilepsy Res 173:106612. https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106612","journal-title":"Epilepsy Res"},{"key":"10208_CR90","doi-asserted-by":"publisher","first-page":"155803","DOI":"10.1016\/j.cyto.2022.155803","volume":"151","author":"D Purrahman","year":"2022","unstructured":"Purrahman D, Mahmoudian-Sani M-R, Saki N, Wojdasiewicz P, Kurkowska-Jastrz\u0119bska I, Poniatowski \u0141A (2022) Involvement of progranulin (PGRN) in the pathogenesis and prognosis of breast cancer. Cytokine 151:155803. https:\/\/doi.org\/10.1016\/j.cyto.2022.155803","journal-title":"Cytokine"},{"key":"10208_CR91","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","volume":"295","author":"RA Quintanilla","year":"2004","unstructured":"Quintanilla RA, Orellana DI, Gonz\u00e1lez-Billault C, Maccioni RB (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway. Exp Cell Res 295:245\u2013257. https:\/\/doi.org\/10.1016\/j.yexcr.2004.01.002","journal-title":"Exp Cell Res"},{"key":"10208_CR92","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1128\/MCB.16.3.1247","volume":"16","author":"J Raingeaud","year":"1996","unstructured":"Raingeaud J, Whitmarsh AJ, Barrett T, D\u00e9rijard B, Davis RJ (1996) MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16:1247\u20131255. https:\/\/doi.org\/10.1128\/MCB.16.3.1247","journal-title":"Mol Cell Biol"},{"key":"10208_CR93","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2174\/1567205014666170203141717","volume":"14","author":"F Regen","year":"2017","unstructured":"Regen F, Hellmann-Regen J, Costantini E, Reale M (2017) Neuroinflammation and Alzheimer\u2019s Disease: Implications for Microglial Activation. Curr Alzheimer Res 14:1140\u20131148. https:\/\/doi.org\/10.2174\/1567205014666170203141717","journal-title":"Curr Alzheimer Res"},{"key":"10208_CR94","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41418-020-00690-y","volume":"28","author":"T Riebeling","year":"2021","unstructured":"Riebeling T, Jamal K, Wilson R, Kolbrink B, von Samson-Himmelstjerna FA, Moerke C, Ramos Garcia L, Dahlke E, Michels F, L\u00fchder F, Schunk D, Doldi P, Tyczynski B, Kribben A, Fl\u00fch C, Theilig F, Kunzendorf U, Meier P, Krautwald S (2021) Primidone blocks RIPK1-driven cell death and inflammation. Cell Death Differ 28:1610\u20131626. https:\/\/doi.org\/10.1038\/s41418-020-00690-y","journal-title":"Cell Death Differ"},{"key":"10208_CR95","doi-asserted-by":"publisher","first-page":"175909142211045","DOI":"10.1177\/17590914221104566","volume":"14","author":"AM Rodr\u00edguez","year":"2022","unstructured":"Rodr\u00edguez AM, Rodr\u00edguez J, Giambartolomei GH (2022) Microglia at the Crossroads of Pathogen-Induced Neuroinflammation. ASN Neuro 14:17590914221104566. https:\/\/doi.org\/10.1177\/17590914221104566","journal-title":"ASN Neuro"},{"key":"10208_CR96","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s12276-021-00634-7","volume":"53","author":"J Seo","year":"2021","unstructured":"Seo J, Nam YW, Kim S, Oh D-B, Song J (2021) Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators. Exp Mol Med 53:1007. https:\/\/doi.org\/10.1038\/s12276-021-00634-7","journal-title":"Exp Mol Med"},{"key":"10208_CR97","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological Alterations in Alzheimer Disease. Cold Spring Harb Perspect Med 1:a006189. https:\/\/doi.org\/10.1101\/cshperspect.a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10208_CR98","doi-asserted-by":"publisher","first-page":"106697","DOI":"10.1016\/j.phrs.2023.106697","volume":"189","author":"F Shi","year":"2023","unstructured":"Shi F, Yuan L, Wong T, Li Q, Li Y, Xu R, You Y, Yuan T, Zhang H, Shi Z, Zha Q, Hu B, He X, Ouyang D (2023) Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis. Pharmacol Res 189:106697. https:\/\/doi.org\/10.1016\/j.phrs.2023.106697","journal-title":"Pharmacol Res"},{"key":"10208_CR99","doi-asserted-by":"publisher","first-page":"24475","DOI":"10.1038\/srep24475","volume":"6","author":"IJ Siddiqui","year":"2016","unstructured":"Siddiqui IJ, Pervaiz N, Abbasi AA (2016) The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication. Sci Rep 6:24475. https:\/\/doi.org\/10.1038\/srep24475","journal-title":"Sci Rep"},{"key":"10208_CR100","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/febs.13968","volume":"284","author":"D Siegmund","year":"2017","unstructured":"Siegmund D, Lang I, Wajant H (2017) Cell death-independent activities of the death receptors CD95, TRAILR1, and TRAILR2. FEBS J 284:1131\u20131159. https:\/\/doi.org\/10.1111\/febs.13968","journal-title":"FEBS J"},{"key":"10208_CR101","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, Wang X (2012) Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase. Cell 148:213\u2013227. https:\/\/doi.org\/10.1016\/j.cell.2011.11.031","journal-title":"Cell"},{"key":"10208_CR102","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12974-021-02182-3","volume":"18","author":"X-Y Sun","year":"2021","unstructured":"Sun X-Y, Li L-J, Dong Q-X, Zhu J, Huang Y-R, Hou S-J, Yu X-L, Liu R-T (2021) Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer\u2019s disease. J Neuroinflammation 18:131. https:\/\/doi.org\/10.1186\/s12974-021-02182-3","journal-title":"J Neuroinflammation"},{"key":"10208_CR103","doi-asserted-by":"publisher","unstructured":"Sun ND, Carr AR, Krogman EN, Chawla Y, Zhong J, Guttormson MC, Chan M, Hsu MA, Dong H, Bogunovic D, Pandey A, Rogers LM, Ting AT (2024) TBK1 and IKK\u03b5 protect target cells from IFN\u03b3-mediated T cell killing via an inflammatory apoptotic mechanism, bioRxiv 2024.08.06.606693. https:\/\/doi.org\/10.1101\/2024.08.06.606693","DOI":"10.1101\/2024.08.06.606693"},{"key":"10208_CR104","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1038\/cddis.2012.176","volume":"3","author":"N Takahashi","year":"2012","unstructured":"Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB, Goossens V, Roelandt R, Van Hauwermeiren F, Libert C, Declercq W, Callewaert N, Prendergast GC, Degterev A, Yuan J, Vandenabeele P (2012) Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 3:e437. https:\/\/doi.org\/10.1038\/cddis.2012.176","journal-title":"Cell Death Dis"},{"key":"10208_CR105","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","volume":"577","author":"P Tao","year":"2020","unstructured":"Tao P, Sun J, Wu Z, Wang S, Wang J, Li W, Pan H, Bai R, Zhang J, Wang Y, Lee PY, Ying W, Zhou Q, Hou J, Wang W, Sun B, Yang M, Liu D, Fang R, Han H, Yang Z, Huang X, Li H, Deuitch N, Zhang Y, Dissanayake D, Haude K, McWalter K, Roadhouse C, MacKenzie JJ, Laxer RM, Aksentijevich I, Yu X, Wang X, Yuan J, Zhou Q (2020) A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature 577:109\u2013114. https:\/\/doi.org\/10.1038\/s41586-019-1830-y","journal-title":"Nature"},{"key":"10208_CR106","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1016\/j.bmcl.2005.07.077","volume":"15","author":"X Teng","year":"2005","unstructured":"Teng X, Degterev A, Jagtap P, Xing X, Choi S, Denu R, Yuan J, Cuny GD (2005) Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett 15:5039\u20135044. https:\/\/doi.org\/10.1016\/j.bmcl.2005.07.077","journal-title":"Bioorg Med Chem Lett"},{"key":"10208_CR107","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.it.2016.06.002","volume":"37","author":"AT Ting","year":"2016","unstructured":"Ting AT, Bertrand MJM (2016) More to life than NF-\u03baB in TNFR1 signaling. Trends Immunol 37:535. https:\/\/doi.org\/10.1016\/j.it.2016.06.002","journal-title":"Trends Immunol"},{"key":"10208_CR108","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E Tolosa","year":"2006","unstructured":"Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson\u2019s disease. Lancet Neurol 5:75\u201386. https:\/\/doi.org\/10.1016\/S1474-4422(05)70285-4","journal-title":"Lancet Neurol"},{"key":"10208_CR109","doi-asserted-by":"publisher","first-page":"102840","DOI":"10.1016\/j.redox.2023.102840","volume":"65","author":"Y Tong","year":"2023","unstructured":"Tong Y, Wu Y, Ma J, Ikeda M, Ide T, Griffin CT, Ding X-Q, Wang S (2023) Comparative mechanistic study of RPE cell death induced by different oxidative stresses. Redox Biol 65:102840. https:\/\/doi.org\/10.1016\/j.redox.2023.102840","journal-title":"Redox Biol"},{"key":"10208_CR110","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2016.08.035","volume":"101","author":"E Varfolomeev","year":"2018","unstructured":"Varfolomeev E, Vucic D (2018) Intracellular regulation of TNF activity in health and disease. Cytokine 101:26\u201332. https:\/\/doi.org\/10.1016\/j.cyto.2016.08.035","journal-title":"Cytokine"},{"key":"10208_CR111","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL (2013) Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group, Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol 12:357\u2013367. https:\/\/doi.org\/10.1016\/S1474-4422(13)70044-9","journal-title":"Lancet Neurol"},{"key":"10208_CR112","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1111\/cts.13317","volume":"15","author":"MFJM Vissers","year":"2022","unstructured":"Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM, Cruz-Herranz A, Huang F, Tong V, Erickson R, Zhu Y, Scearce-Levie K, Hsiao-Nakamoto J, Tang X, Chang M, Fox BM, Estrada AA, Pomponio RJ, Alonso-Alonso M, Zilberstein M, Atassi N, Troyer MD, Ho C (2022) Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I\/Ib studies in healthy subjects and patients. Clin Transl Sci 15:2010\u20132023. https:\/\/doi.org\/10.1111\/cts.13317","journal-title":"Clin Transl Sci"},{"key":"10208_CR113","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.immuni.2023.05.017","volume":"56","author":"M Vucur","year":"2023","unstructured":"Vucur M, Ghallab A, Schneider AT, Adili A, Cheng M, Castoldi M, Singer MT, B\u00fcttner V, Keysberg LS, K\u00fcsgens L, Kohlhepp M, G\u00f6rg B, Gallage S, Barragan Avila JE, Unger K, Kordes C, Leblond A-L, Albrecht W, Loosen SH, Lohr C, J\u00f6rdens MS, Babler A, Hayat S, Schumacher D, Koenen MT, Govaere O, Boekschoten MV, J\u00f6rs S, Villacorta-Martin C, Mazzaferro V, Llovet JM, Weiskirchen R, Kather JN, Starlinger P, Trauner M, Luedde M, Heij LR, Neumann UP, Keitel V, Bode JG, Schneider RK, Tacke F, Levkau B, Lammers T, Fluegen G, Alexandrov T, Collins AL, Nelson G, Oakley F, Mann DA, Roderburg C, Longerich T, Weber A, Villanueva A, Samson AL, Murphy JM, Kramann R, Geisler F, Costa IG, Hengstler JG, Heikenwalder M, Luedde T (2023) Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity 56:1578-1595.e8. https:\/\/doi.org\/10.1016\/j.immuni.2023.05.017","journal-title":"Immunity"},{"key":"10208_CR114","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/s41418-019-0457-8","volume":"27","author":"T Wang","year":"2019","unstructured":"Wang T, Perera ND, Chiam MDF, Cuic B, Wanniarachchillage N, Tomas D, Samson AL, Cawthorne W, Valor EN, Murphy JM, Turner BJ (2019) Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS. Cell Death Differ 27:1728. https:\/\/doi.org\/10.1038\/s41418-019-0457-8","journal-title":"Cell Death Differ"},{"key":"10208_CR115","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s40478-021-01236-0","volume":"9","author":"AC Wehn","year":"2021","unstructured":"Wehn AC, Khalin I, Duering M, Hellal F, Culmsee C, Vandenabeele P, Plesnila N, Terpolilli NA (2021) RIPK1 or RIPK3 deletion prevents progressive neuronal cell death and improves memory function after traumatic brain injury. Acta Neuropathol Commun 9:138. https:\/\/doi.org\/10.1186\/s40478-021-01236-0","journal-title":"Acta Neuropathol Commun"},{"key":"10208_CR116","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41392-023-01713-z","volume":"8","author":"J Wei","year":"2023","unstructured":"Wei J, Li M, Ye Z, Hu X, He X, Wang J, Chen G, Zou C, Xu D, Zhang H, Yuan J, Zha Y (2023) Elevated peripheral levels of receptor-interacting protein kinase 1 (RIPK1) and IL-8 as biomarkers of human amyotrophic lateral sclerosis. Signal Transduct Target Ther 8:451. https:\/\/doi.org\/10.1038\/s41392-023-01713-z","journal-title":"Signal Transduct Target Ther"},{"key":"10208_CR117","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nrm.2016.149","volume":"18","author":"R Weinlich","year":"2017","unstructured":"Weinlich R, Oberst A, Beere HM, Green DR (2017) Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol 18:127\u2013136. https:\/\/doi.org\/10.1038\/nrm.2016.149","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10208_CR118","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","volume":"430","author":"IE Wertz","year":"2004","unstructured":"Wertz IE, O\u2019Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430:694\u2013699. https:\/\/doi.org\/10.1038\/nature02794","journal-title":"Nature"},{"key":"10208_CR119","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature16165","volume":"528","author":"IE Wertz","year":"2015","unstructured":"Wertz IE, Newton K, Seshasayee D, Kusam S, Lam C, Zhang J, Popovych N, Helgason E, Schoeffler A, Jeet S, Ramamoorthi N, Kategaya L, Newman RJ, Horikawa K, Dugger D, Sandoval W, Mukund S, Zindal A, Martin F, Quan C, Tom J, Fairbrother WJ, Townsend M, Warming S, DeVoss J, Liu J, Dueber E, Caplazi P, Lee WP, Goodnow CC, Balazs M, Yu K, Kolumam G, Dixit VM (2015) Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 528:370\u2013375. https:\/\/doi.org\/10.1038\/nature16165","journal-title":"Nature"},{"key":"10208_CR120","doi-asserted-by":"publisher","first-page":"101941","DOI":"10.1016\/j.berh.2024.101941","volume":"38","author":"RO Williams","year":"2024","unstructured":"Williams RO, Clanchy FIL, Huang Y-S, Tseng W-Y, Stone TW (2024) TNFR2 signalling in inflammatory diseases, Best Practice & Research. Clin Rheumatol 38:101941. https:\/\/doi.org\/10.1016\/j.berh.2024.101941","journal-title":"Clin Rheumatol"},{"key":"10208_CR121","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41419-020-2534-9","volume":"11","author":"Y-H Wu","year":"2020","unstructured":"Wu Y-H, Chou T-F, Young L, Hsieh F-Y, Pan H-Y, Mo S-T, Brown SB, Chen R-H, Kimchi A, Lai M-Z (2020) Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation. Cell Death Dis 11:305. https:\/\/doi.org\/10.1038\/s41419-020-2534-9","journal-title":"Cell Death Dis"},{"key":"10208_CR122","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1038\/s41598-017-06088-0","volume":"7","author":"X-S Yang","year":"2017","unstructured":"Yang X-S, Yi T-L, Zhang S, Xu Z-W, Yu Z-Q, Sun H-T, Yang C, Tu Y, Cheng S-X (2017) Hypoxia-inducible factor-1 alpha is involved in RIP-induced necroptosis caused by in vitro and in vivo ischemic brain injury. Sci Rep 7:5818. https:\/\/doi.org\/10.1038\/s41598-017-06088-0","journal-title":"Sci Rep"},{"key":"10208_CR123","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1093\/cercor\/bhy089","volume":"28","author":"J Yang","year":"2018","unstructured":"Yang J, Zhao Y, Zhang L, Fan H, Qi C, Zhang K, Liu X, Fei L, Chen S, Wang M, Kuang F, Wang Y, Wu S (2018) RIPK3\/MLKL-Mediated Neuronal Necroptosis Modulates the M1\/M2 Polarization of Microglia\/Macrophages in the Ischemic Cortex. Cereb Cortex 28:2622\u20132635. https:\/\/doi.org\/10.1093\/cercor\/bhy089","journal-title":"Cereb Cortex"},{"key":"10208_CR124","doi-asserted-by":"publisher","first-page":"e202114922","DOI":"10.1002\/anie.202114922","volume":"61","author":"X Yang","year":"2022","unstructured":"Yang X, Lu H, Xie H, Zhang B, Nie T, Fan C, Yang T, Xu Y, Su H, Tang W, Zhou B (2022) Potent and Selective RIPK1 Inhibitors Targeting Dual-Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis. Angew Chem Int Ed Engl 61:e202114922. https:\/\/doi.org\/10.1002\/anie.202114922","journal-title":"Angew Chem Int Ed Engl"},{"key":"10208_CR125","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41419-023-05691-6","volume":"14","author":"K Ye","year":"2023","unstructured":"Ye K, Chen Z, Xu Y (2023) The double-edged functions of necroptosis. Cell Death Dis 14:163. https:\/\/doi.org\/10.1038\/s41419-023-05691-6","journal-title":"Cell Death Dis"},{"key":"10208_CR126","doi-asserted-by":"publisher","first-page":"701564","DOI":"10.3389\/fphar.2021.701564","volume":"12","author":"Z Yu","year":"2021","unstructured":"Yu Z, Jiang N, Su W, Zhuo Y (2021) Necroptosis: A Novel Pathway in Neuroinflammation. Front Pharmacol 12:701564. https:\/\/doi.org\/10.3389\/fphar.2021.701564","journal-title":"Front Pharmacol"},{"key":"10208_CR127","doi-asserted-by":"publisher","first-page":"2105442","DOI":"10.1002\/advs.202105442","volume":"9","author":"Z Yu","year":"2022","unstructured":"Yu Z, Fang X, Liu W, Sun R, Zhou J, Pu Y, Zhao M, Sun D, Xiang Z, Liu P, Ding Y, Cao L, He C (2022) Microglia Regulate Blood-Brain Barrier Integrity via MiR-126a-5p\/MMP9 Axis during Inflammatory Demyelination. Adv Sci (Weinh) 9:2105442. https:\/\/doi.org\/10.1002\/advs.202105442","journal-title":"Adv Sci (Weinh)"},{"key":"10208_CR128","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan J, Amin P, Ofengeim D (2019) Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci 20:19\u201333. https:\/\/doi.org\/10.1038\/s41583-018-0093-1","journal-title":"Nat Rev Neurosci"},{"key":"10208_CR129","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/antiox10091347","volume":"10","author":"H Yuk","year":"2021","unstructured":"Yuk H, Abdullah M, Kim D-H, Lee H, Lee S-J (2021) Necrostatin-1 Prevents Ferroptosis in a RIPK1- and IDO-Independent Manner in Hepatocellular Carcinoma. Antioxidants (Basel) 10:1347. https:\/\/doi.org\/10.3390\/antiox10091347","journal-title":"Antioxidants (Basel)"},{"key":"10208_CR130","doi-asserted-by":"publisher","first-page":"109112","DOI":"10.1016\/j.celrep.2021.109112","volume":"35","author":"M Zelic","year":"2021","unstructured":"Zelic M, Pontarelli F, Woodworth L, Zhu C, Mahan A, Ren Y, LaMorte M, Gruber R, Keane A, Loring P, Guo L, Xia T, Zhang B, Orning P, Lien E, Degterev A, Hammond T, Ofengeim D (2021) RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis. Cell Rep 35:109112. https:\/\/doi.org\/10.1016\/j.celrep.2021.109112","journal-title":"Cell Rep"},{"key":"10208_CR131","doi-asserted-by":"publisher","first-page":"14329","DOI":"10.1038\/ncomms14329","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Su SS, Zhao S, Yang Z, Zhong C-Q, Chen X, Cai Q, Yang Z-H, Huang D, Wu R, Han J (2017a) RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun 8:14329. https:\/\/doi.org\/10.1038\/ncomms14329","journal-title":"Nat Commun"},{"key":"10208_CR132","doi-asserted-by":"publisher","first-page":"e2905","DOI":"10.1038\/cddis.2017.286","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang S, Tang M-B, Luo H-Y, Shi C-H, Xu Y-M (2017b) Necroptosis in neurodegenerative diseases: a potential therapeutic target. Cell Death Dis 8:e2905. https:\/\/doi.org\/10.1038\/cddis.2017.286","journal-title":"Cell Death Dis"},{"key":"10208_CR133","doi-asserted-by":"publisher","first-page":"749587","DOI":"10.3389\/fncel.2021.749587","volume":"15","author":"G Zhang","year":"2021","unstructured":"Zhang G, Wang Z, Hu H, Zhao M, Sun L (2021) Microglia in Alzheimer\u2019s Disease: A Target for Therapeutic Intervention. Front Cell Neurosci 15:749587. https:\/\/doi.org\/10.3389\/fncel.2021.749587","journal-title":"Front Cell Neurosci"},{"key":"10208_CR134","doi-asserted-by":"publisher","first-page":"e1011792","DOI":"10.1371\/journal.ppat.1011792","volume":"19","author":"X Zhang","year":"2023","unstructured":"Zhang X, Yang Z, Pan T, Sun Q, Chen Q, Wang P-H, Li X, Kuang E (2023a) SARS-CoV-2 Nsp8 suppresses MDA5 antiviral immune responses by impairing TRIM4-mediated K63-linked polyubiquitination. PLoS Pathog 19:e1011792. https:\/\/doi.org\/10.1371\/journal.ppat.1011792","journal-title":"PLoS Pathog"},{"key":"10208_CR135","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1021\/acschemneuro.3c00250","volume":"14","author":"Y-Y Zhang","year":"2023","unstructured":"Zhang Y-Y, Peng J-J, Chen D, Liu H-Q, Yao B-F, Peng J, Luo X-J (2023b) Telaprevir Improves Memory and Cognition in Mice Suffering Ischemic Stroke via Targeting MALT1-Mediated Calcium Overload and Necroptosis. ACS Chem Neurosci 14:3113\u20133124. https:\/\/doi.org\/10.1021\/acschemneuro.3c00250","journal-title":"ACS Chem Neurosci"},{"key":"10208_CR136","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/biom14101204","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Huang Y, Cao Y, Yang J (2024) Astrocyte-Mediated Neuroinflammation in Neurological Conditions. Biomolecules 14:1204. https:\/\/doi.org\/10.3390\/biom14101204","journal-title":"Biomolecules"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-025-10208-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:42:42Z","timestamp":1748259762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-025-10208-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10208"],"URL":"https:\/\/doi.org\/10.1007\/s11481-025-10208-3","relation":{},"ISSN":["1557-1904"],"issn-type":[{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"59"}}